DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Herceptin (Trastuzumab) - Current Clinical Trials

 
 



Herceptin Related Clinical Trials

A Study of the Efficacy and Safety of Trastuzumab Emtansine (Trastuzumab-MCC-DM1) vs. Trastuzumab (Herceptin«) and Docetaxel (Taxotere«) in Patients With Metastatic HER2-positive Breast Cancer Who Have Not Received Prior Chemotherapy for Metastatic Disease [Completed]

Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer [Completed]

CPG 7909 Plus Herceptin´┐Ż In Patients With Metastatic Breast Cancer [Completed]

A Phase 1/2 Study Of HKI-272 (Neratinib) in Combination With Trastuzumab (Herceptin) In Subjects With Advanced Breast Cancer [Active, not recruiting]

MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer [Completed]

A Safety and Efficacy Study of BCD-022 With Paclitaxel Compared to Herceptin With Paclitaxel in HER2-Positive Metastatic Breast Cancer Patients [Active, not recruiting]

Study of Efficacy and Safety of Hercules(Myl1401O Mylan Trastuzumab) + Taxane vs Herceptin┬ę+ Taxane for 1st Line, Met. Br. Ca. [Active, not recruiting]

Docetaxel and Trastuzumab With or Without Carboplatin in Treating Women With HER2-Positive Breast Cancer [Completed]

A Pharmacokinetic Study Comparing PF-05280014 And Trastuzumab In Healthy Male Volunteers (REFLECTIONS B327-01) [Completed]

Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer [Recruiting]

Neoadjuvant Herceptin in Patients With Breast Cancer [Terminated]

Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast Cancer [Completed]

Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax [Recruiting]

A Study of Trastuzumab Emtansine (Trastuzumab-MCC-DM1, T-DM1) in Combination With Pertuzumab Administered to Patients With Human Epidermal Growth Factor Receptor-2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer Who Have Previously Received Trastuzumab [Completed]

Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer [Completed]

Trastuzumab and RAD001 in Patients With Human Epidermal Growth Receptor 2 (HER-2) Overexpressing Breast Cancer [Completed]

A Study Of PF-05280014 Or Trastuzumab Plus Taxotere« And Carboplatin In HER2 Positive Breast Cancer In The Neoadjuvant Setting (REFLECTIONS B327-04) [Recruiting]

Multimodality Treatment for Women With Stage II, Stage III, or Stage IV Breast Cancer [Completed]

Feasibility Study of Chemoradiation, TRAstuzumab and Pertuzumab in Resectable HER2+ Esophageal Carcinoma [Recruiting]

Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid Tumors [Completed]

Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer [Completed]

Patients' Preference of Herceptin (Trastuzumab) Subcutaneous Versus Intravenous Administration in HER2-positive Early Breast Cancer [Active, not recruiting]

Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast [Completed]

Dose Escalation Followed by Study of RAD001 in Combination With Trastuzumab in HER2-Positive Metastatic Breast Cancer [Active, not recruiting]

A Study of Subcutaneously Administered Herceptin (Trastuzumab) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer [Terminated]

Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients [Recruiting]

A Study to Compare the Effect of SB3 and Herceptin« in Women With HER2 Positive Breast Cancer [Recruiting]

Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2 [Active, not recruiting]

Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients [Active, not recruiting]

Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast Cancer [Completed]

Effects of Granulocyte Colony-stimulating Factor (G-CSF), Trastuzumab, and Vinorelbine on Immune Cell Function [Terminated]

Preoperative Herceptin and Navelbine for Breast Cancer [Active, not recruiting]

Agatolimod and Trastuzumab in Treating Patients With Locally Advanced or Metastatic Breast Cancer [Active, not recruiting]

Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer [Recruiting]

Study of Gemcitabine and Herceptin Versus Xeloda and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients [Terminated]

Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer [Active, not recruiting]

Early Predictor of Herceptin Cardiotoxicity [Recruiting]

Herceptin and GM-CSF for Metastatic Breast Cancer [Completed]

ToGA Study - A Study of Herceptin (Trastuzumab) in Combination With Chemotherapy Compared With Chemotherapy Alone in Patients With HER2-Positive Advanced Gastric Cancer [Completed]

Efficacy and Safety of IPI-504 With Trastuzumab Pretreated, Locally Advanced or Metastatic HER2 Positive Breast Cancer [Terminated]

Neoadjuvant TDM1 With Lapatinib and Abraxane Compared With Trastuzumab With Lapatinib and Paclitaxel [Recruiting]

Phase 1b/2 Study of U3-1287 in Combination With Trastuzumab Plus Paclitaxel in Newly Diagnosed Metastatic Breast Cancer (MBC) [Active, not recruiting]

Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer [Completed]

Intrathecal Trastuzumab for Leptomeningeal Metastases in HER2+ Breast Cancer [Recruiting]

GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases [Active, not recruiting]

Safety and QoL of Trastuzumab With Lapatinib or Chemiotherapy in MBC and HER2+ Patients Refractory to Anti HER2 Therapies [Recruiting]

Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous Meningitis [Recruiting]

Breast Cancer Treatment Using Weekly Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting [Recruiting]

A Phase II Study of Rapamycin and Trastuzumab for Patients With HER-2 Receptor Positive Metastatic Breast Cancer [Recruiting]

Phase I Open Label Trial to Assess Safety of BIBW 2992 (Afatinib) in Combination With Herceptin« in Patients With HER2-positive Advanced Breast Cancer. [Completed]

A Study of Herceptin (Trastuzumab) in Women With Metastatic Breast Cancer [Completed]

MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients [Recruiting]

Study With Docetaxel, Carboplatin and Herceptin Versus Vinorelbine and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients [Terminated]

A Phase III Clinical Trial to Evaluate Patient┬┤s Preference of Subcutaneous Trastuzumab (SC) Versus Intravenous (IV) Administration in Patients With HER2 Positive Advanced Breast Cancer (ABC). [Recruiting]

Safety Study of ┬▓┬╣┬▓Pb-TCMC-Trastuzumab Radio Immunotherapy [Active, not recruiting]

Trastuzumab in Combination With AMG 479 in HER-2 Overexpressing MBC Progressing on Trastuzumab [Withdrawn]

Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer [Terminated]

Phase I/II Trial of Ruxolitinib in Combination With Trastuzumab in Metastatic HER2 Positive Breast Cancer [Recruiting]

Cisplatin and Gemcitabine Plus Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Completed]

Trastuzumab Optimization Trial in Breast Cancer [Recruiting]

A Study to Evaluate the Efficacy and Safety of Herceptin« (Trastuzumab) in Combination With Arimidex« (Anastrozole) an Aromatase Inhibitor Compared to Arimidex« Alone in Patients With Metastatic Breast Cancer [Completed]

A Study of Patient Satisfaction and Safety With Subcutaneously Administered Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer [Recruiting]

Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic [Completed]

Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Locally Advanced Breast Cancer [Completed]

Trastuzumab in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer [Terminated]

Experience of the Patient Treated With Trastuzumab (Herceptin «) as Adjuvant for Breast Cancer [Active, not recruiting]

Taxotere«, Eloxatin« and Xeloda« (TEX) in Combination With Herceptin« as Treatment for HER2 Positive Non-resectable Cancer [Recruiting]

Efficacy and Safety Study of Trastuzumab, Paclitaxel and Carboplatin on HER2+ Preoperative Breast Cancer [Recruiting]

A Study Inhibiting Telomerase to Reverse Trastuzumab Resistance in HER2+ Breast Cancer [Active, not recruiting]

Study of Albumin-bound Paclitaxel (Abraxane) in Combination With Carboplatin and Herceptin in Patients With Advanced Breast Cancer [Completed]

Real World Efficiency of Trastuzumab in Early Breast Cancer [Completed]

A Study Of Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain Metastases [Recruiting]

Study of XL147 (SAR245408) in Combination With Trastuzumab or Paclitaxel and Trastuzumab in Subjects With Metastatic Breast Cancer Who Have Progressed on a Previous Trastuzumab-based Regimen [Completed]

Phase II Study of Trastuzumab Plus Docetaxel and Capecitabine For First Line Treatment of Her2-Positive Advanced Gastric Cancer [Recruiting]

Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer [Active, not recruiting]

Six vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer [Completed]

Randomized Trial With Trastuzumab Versus Observation in Breast Cancer Patients [Completed]

Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for the Treatment of HER-2/Neu-Overexpressing Metastatic Breast Cancer [Completed]

Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium [Terminated]

A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Patients With Metastatic or Locally Advanced Breast Cancer [Completed]

A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer (CLEOPATRA) [Active, not recruiting]

Entinostat, Lapatinib Ditosylate and Trastuzumab in Treating Patients With Locally Recurrent or Distant Relapsed Metastatic Breast Cancer Previously Treated With Trastuzumab Only [Recruiting]

A Study of Trastuzumab Emtansine (T-DM1) Sequentially With Anthracycline-based Chemotherapy, as Adjuvant or Neoadjuvant Therapy for Patients With Early Stage Herceptin (HER)2-positive Breast Cancer [Completed]

Trastuzumab and Flavopiridol in Treating Patients With Metastatic Breast Cancer [Terminated]

A Study Evaluating The Safety Of PF-05280014 And Trastuzumab In Healthy Male Volunteers (REFLECTIONS B327-06) [Completed]

Trastuzumab in Combination With Capecitabine and Oxaliplatin(XELOX) in Patients With Advanced Gastric Cancer(AGC) [Active, not recruiting]

A Study of Trastuzumab Emtansine (Trastuzumab-MCC-DM1) Administered Intravenously to Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer [Completed]

Study Of SU011248 In Combination With Docetaxel And Trastuzumab In Patients With Advanced Breast Cancer HER-2 Positive [Completed]

Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery [Terminated]

Efficacy of Combination of Trastuzumab to Gemcitabine - Platinum Advanced or Metastatic Urothelial Carcinoma [Active, not recruiting]

Adj TC + Herceptin Early Stage Breast Cancer [Completed]

NeoPHOEBE: Neoadjuvant Trastuzumab + BKM120 in Combination With Weekly Paclitaxel in HER2-positive Primary Breast Cancer [Recruiting]

Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract Cancer [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015